ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000940.1|Desferrioxamine_1 # 1 # 510 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000940.1|Desferrioxamine_1 	1	510	+	Loose	200	25.409	BLMT	40.74	3005036	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic inactivation	Bleomycin resistant protein	CAGCGCATGTGGGAGCTGGCGGAGTCGCTCGGCGCGGACATGAAGGCCAAGAAGGTCACCGACGCCAAGGCCGCCTTCGACAAGGCCGCCGCCCGGCTGCGCGCCGCCGCCAAGGCCAAGCCGGAGATCCGGGTGCTGGCCGGTTCCGCGAGCCCCGACCTGTTCTACGTCTCCGGCACCAACCTCTCGGTGGACCTGGAGTACTTCAAGGCCCTCGGCGTGAACTTCGTCGAGCCCTCCGAGGACGCCAAGAAGGCGACCGGCGGCTGGTTCGAGTCCCTGAGCTGGGAGAACGTCGACAAGTACCCGGCCGACGTCATCATCATGGACGACCGCGCCTCGACCATCCAGCCCGCCGACATCACCGAGGGCACCTGGAAGCAGCTCCCCGCGGTCAAGGCCGGACAGGTCATCGCCCGCTCCCCCGAGCCGATCCTGTCCTACGACAAGTGCACGCCGCTCCTCGACAACCTGGCCGAGGCGATCGAGAACGCCAAGAAGGTCGGCTGA	QRMWELAESLGADMKAKKVTDAKAAFDKAAARLRAAAKAKPEIRVLAGSASPDLFYVSGTNLSVDLEYFKALGVNFVEPSEDAKKATGGWFESLSWENVDKYPADVIIMDDRASTIQPADITEGTWKQLPAVKAGQVIARSPEPILSYDKCTPLLDNLAEAIENAKKVG	MTDQATPNLPSRDFDSTAAFYERLGFGIVFRDAGWMILQRGDLMLEFFAHPGLDPLASWFSCCLRLDDLAEFYRQCKSVGIQETSSGYPRIHAPELQEWGGTMAALVDPDGTLLRLIQNELLAGIS	134.13	gnl|BL_ORD_ID|2776|hsp_num:0	3789			159	240	bleomycin
BGC0000940.1|Desferrioxamine_2 # 537 # 1583 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.749	BGC0000940.1|Desferrioxamine_2 	537	1583	+	Loose	500	25.7942	OXA-553	45.83	3005777	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGGACGGCCGTCGCCGCCCCGTTCCGTTTCTTCGCCCTCCAGGTCGTACGGACGAGGCGGTTGGGGGGTGTCGATTGGATCAGGCCGGCTCCGGCCAACGGTGCTTCGCTGCCGACCCGAGCGGGGTCCGGTGCGTGCAGCTGCACGGCGGAGGAGGGCGACAGGGCGGAGCCCCGGCAACCGACGACAACGCCGCAGATGCGCGTGCCAGACCCCGCGCCCCCGGCAGGATCCAAACGACACCCCCCAAGCCCGGCCCTGGCCCGGGTCACCTTCGCGGGGCCCGACCTGCGCGCCTTCCGCTCCGACGGCCTCGACCAGTCGCTGTCGCTGTTCCTGCCGCACCCGGGGCAGGCGGAGCCCGCGGTCCCGGTGGAGCTGGGCGAGGGCTGGTGGCAGGGCTGGCGGGAACTGCCGGAGGACGTACGGGCGGTGATGCGCTCGTACACGCTGCGGTCACTGCGCCGCGACACCGACGGGCACACCGCCGAGATCGACGTCGACTTCGTCCTGCACGGCCTCGAACCGGACTCGGGGATCCAGGCCGGTCCCGCCGCCCGCTGGGCCGCCGACGCCGCCCCCGGCGACCGCGTGCTGCTGCTCGGCCCGGCGGTCGCCGACAACCGGGCGATCCGCTTCCGGCCGCCCGAGGACACCGACCTGGTGGTGATCTGGGGTGACGAGACAGCCGTACCCGCCGCCTGCGCCATCGTGGAGGCACTGCCGGCCGGCACCCGCGCGCGGGTCTGGCTTCAGGTGCCGCACGCCGAGGACGTGCAGGACCTCCGGACGGCCGCGGACGCCGAGATCACCTGGCTGGTCGGGGACGCCGCCGACGGGCCCGAGGCGACCCTCGCCACCCTCCGCGCCGCCCAACTGCCGCCCGCCGAACACCCCTACGTCTGGATCGCGGGCGAGTCCGGCTGCGTGAAGCGGCTGCGGCGGCACTTCGTGGGCGAGCGCGGCGTCGACCGACGGCGCGTCACCTTCGTCGGCTACTGGCGCCGGGGCCTGACGGAGGAACAACTCCGCGAGCAGGGCTGA	MRTAVAAPFRFFALQVVRTRRLGGVDWIRPAPANGASLPTRAGSGACSCTAEEGDRAEPRQPTTTPQMRVPDPAPPAGSKRHPPSPALARVTFAGPDLRAFRSDGLDQSLSLFLPHPGQAEPAVPVELGEGWWQGWRELPEDVRAVMRSYTLRSLRRDTDGHTAEIDVDFVLHGLEPDSGIQAGPAARWAADAAPGDRVLLLGPAVADNRAIRFRPPEDTDLVVIWGDETAVPAACAIVEALPAGTRARVWLQVPHAEDVQDLRTAADAEITWLVGDAADGPEATLATLRAAQLPPAEHPYVWIAGESGCVKRLRRHFVGERGVDRRRVTFVGYWRRGLTEEQLREQG	MRSFAISTVLVMSSLLASSIIAAPTFASTAVKKEWQETRSWDAIFTQHQVEPQQAKQQQAKPQKTKSQQTSGVVALWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDISGNLDSFWLDGGIRISATEQIDFLRRLYYNKIHASERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWIELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP	117.97	gnl|BL_ORD_ID|3812|hsp_num:0	4882			732	786	cloxacillin; oxacillin; cefalotin
BGC0000940.1|Desferrioxamine_3 # 1747 # 3189 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.704	BGC0000940.1|Desferrioxamine_3 	1747	3189	+	Loose	575	29.261	MBL1b	29.49	3006951	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MBL beta-lactamase	ATGCGCTCGCACCTGCTCAACGACACCACCGCGGAGCAGTACCGCCGTTCCGTGACCGAAGGAGTCGAGCGGGTGGCCGCCAAACTCGCCACCACCGACCGCCCGTTCACCGGCGTCACGGTCGACGCCCTCTCCCCCCGCATCGACGCGATCGACCTCGACGAGCCGCTGCACGACACCGCCGCGGTCCTCGACGAGCTGGAGGACGTCTACCTCCGCGACGCCGTCTACTTCCACCACCCCCGCTACCTCGCCCACCTCAACTGCCCGGTCGTCATACCGGCGCTGCTCGGTGAAGCGGTCCTGTCCGCCGTCAACTCCTCCCTGGACACCTGGGACCAGTCGGCCGGCGGCACGCTCATCGAGCGGAAGCTGATCGACTGGACCTGCGCCCGCATCGGCCTCGGCCCGGCGGCCGACGGCGTGTTCACCTCCGGCGGCACCCAGTCCAACCTCCAGGCGCTGCTCCTCGCCCGCGAGGAGGCGAAGGCCGAGGACTTCGCCGACCTGCGGATCTTCGCCTCCGAGGCCAGCCACTTCAGCGTCAGGAAGTCCGCGAAACTGCTCGGCCTCGGCCCCGACGCCGTCGTGTCGATCCCGGTCGACCGCGACAAGCGGATGCAGACCGTCGCCCTCGCCCGCGAGCTGGAGCGCTGCGCGCGGGACGGCCTGGTCCCCATGGCCGTCGTCGCCACCGGCGGCACCACCGACTTCGGCTCGATCGACCCGCTGCCGGAGATCGCCGGGCTGTGCGAGCAGTACGGCGTGTGGATGCACGTCGACGCGGCCTACGGCTGCGGGCTGCTCGCCTCCCTGAAGTACCGGGACCGCATCACCGGCATCGAGCGGGCCGACTCGGTCACCGTGGACTACCACAAGTCCTTCTTCCAGCCGGTGAGTTCGTCGGCCGTGCTGGTCCGGGACGCGGCCACCCTGCGCCACGCCACCTACCACGCGGAGTACCTCAACCCGCGCCGCATGGTGCAGGAACGTATCCCCAACCAGGTGGACAAGTCCCTCCAGACCACCCGCCGCTTCGACGCGCTCAAGCTGTGGATGACGCTGCGCGTGATGGGCGCCGACGGCATCGGCGTCCTCTTCGACGAGGTGTGCGACCTGGCCGCCGAGGGCTGGAAACTGCTCGCCGCCGACCCGCGCTTCGACGTCGTGGTCCAGCCGTCGCTGTCCACGCTGGTCTTCCGCCACATCCCGGCGGACGTCACCGATCCCGCCGAGATCGACCGCGCCAACCTGTACGCCCGCAAGGCCCTGTTCGCGTCCGGCGACGCCGTGGTCGCGGGCACCAAGGTCGCCGGTCGCCACTACCTGAAGTTCACCCTGCTCAACCCCGAGACGACCCCGGCCGACATCGCCGCCGTCCTCGACCTGATCGCCGGCCACGCCGAGCAGTACCTGGGAGACTCCCTTGACCGCGCTTCCTGA	MRSHLLNDTTAEQYRRSVTEGVERVAAKLATTDRPFTGVTVDALSPRIDAIDLDEPLHDTAAVLDELEDVYLRDAVYFHHPRYLAHLNCPVVIPALLGEAVLSAVNSSLDTWDQSAGGTLIERKLIDWTCARIGLGPAADGVFTSGGTQSNLQALLLAREEAKAEDFADLRIFASEASHFSVRKSAKLLGLGPDAVVSIPVDRDKRMQTVALARELERCARDGLVPMAVVATGGTTDFGSIDPLPEIAGLCEQYGVWMHVDAAYGCGLLASLKYRDRITGIERADSVTVDYHKSFFQPVSSSAVLVRDAATLRHATYHAEYLNPRRMVQERIPNQVDKSLQTTRRFDALKLWMTLRVMGADGIGVLFDEVCDLAAEGWKLLAADPRFDVVVQPSLSTLVFRHIPADVTDPAEIDRANLYARKALFASGDAVVAGTKVAGRHYLKFTLLNPETTPADIAAVLDLIAGHAEQYLGDSLDRAS	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLHGGPNAETGKLVERNITALGFQLADLKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPKP	166.09	gnl|BL_ORD_ID|3692|hsp_num:0	4762			534	762	
BGC0000940.1|Desferrioxamine_4 # 3173 # 4453 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.680	BGC0000940.1|Desferrioxamine_4 	3173	4453	+	Loose	525	28.4906	myrA	57.14	3001300	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	TTGACCGCGCTTCCTGAAGCCAGCGCCCCGTACGACTTCGTGGGCATCGGCCTCGGCCCCTTCAACCTCGGCCTCGCCTGCCTCACCGAGCCCGTCGCCGAGCTGAACGGCGTCTTCCTGGAGTCCAAGCCGGACTTCGAGTGGCACGCCGGGATGTTCCTGGACGGCGCCCACCTCCAGACCCCGTTCATGTCGGACCTGGTGACGCTCGCCGACCCGACCTCGCCGTACTCCTTCCTCAACTACCTGAAGGAGCAGGGCCGGCTGTACTCCTTCTACATCCGGGAGAACTTCTACCCGCTGCGGGTCGAGTACGACGACTACTGCCGCTGGGCCGCGCGCAAGCTGAGCAGCGTCCGCTTCTCCACCACGGTCACCGAGGTCACGTACGACGAGCGCGAGGAGCTGTACGCCGTCGCCACCACGTCCGGCGACACCTACCGCGCCCGCCGCCTCGTCCTCGGCACCGGCACCCCGCCGCACATCCCGGACGCCTGCCGGGGCCTGGCCGGCGACTTCCTCCACAACTCCCGGTACGTGCGGCACCGGGCGGAGCTGGTGAAGAAGAAGTCGATCACGCTGGTCGGCAGCGGCCAGTCCGCCGCCGAGATCTACCAGGACCTGCTGAGCGAGATCGACGTCCACGGCTACGGGCTGAACTGGGTGACCCGCTCCCCGCGGTTCTTCCCGCTCGAATACACCAAGCTCACCCTGGAGATGACGTCCCCGGAGTACGTGGACTACTACCACGCGCTGCCCGAGGACACCCGCTACCGCCTCACGGCCGAGCAGAAGGGCCTGTTCAAGGGCATCGACGGCGACCTGATCAACGAGATCTTCGACCTGCTCTACCAGAAACGGCTCGGCGGCCCCGTCCCCACCCGCCTGCTCACCAACTCGGCGCTGACCAGCGCCCGGTATGCGGACGGCACCTACACGCTCGGGTTCCGCCAGGAGGAGCAGGGCACGGACTTCGAGATCGAGACCGAGGGCCTGGTCCTCGCCACCGGCTACCGGTACACCGAGCCGGAGTTCCTCAAGCCCGTCCGGGACCGGCTGCGCTACGACTCCCGCGGCAACTTCGACATCGGCCGCAACTACGCCGTCGACGTCACGGGAGGCGGCGTGTTCCTCCAGAACGCGGGGGTCCACGCGCACAGCGTCACCAGCCCCGACCTGGGCATGGGCGCCTACCGCAACAGCTGCATCGTCCGGGAGCTGCTCGGACGCGAGTACTACCCGGTCGAGCAGTCGATCGCGTTCCAGGAGTTCGCCGTATGA	MTALPEASAPYDFVGIGLGPFNLGLACLTEPVAELNGVFLESKPDFEWHAGMFLDGAHLQTPFMSDLVTLADPTSPYSFLNYLKEQGRLYSFYIRENFYPLRVEYDDYCRWAARKLSSVRFSTTVTEVTYDEREELYAVATTSGDTYRARRLVLGTGTPPHIPDACRGLAGDFLHNSRYVRHRAELVKKKSITLVGSGQSAAEIYQDLLSEIDVHGYGLNWVTRSPRFFPLEYTKLTLEMTSPEYVDYYHALPEDTRYRLTAEQKGLFKGIDGDLINEIFDLLYQKRLGGPVPTRLLTNSALTSARYADGTYTLGFRQEEQGTDFEIETEGLVLATGYRYTEPEFLKPVRDRLRYDSRGNFDIGRNYAVDVTGGGVFLQNAGVHAHSVTSPDLGMGAYRNSCIVRELLGREYYPVEQSIAFQEFAV	MHPDLLPHLRCPVCGQPLHQADAAPPRALRCPAGHSFDIARQGYVNLLTGRAPHVGDTAEMIAAREEFLAAGHYDPFSAALATAAARAVPRRVRPGDGVGEPVAYPDLVVDAGAGTGRHLAAVLDAVPTAVGLALDVSKPALRRAARAHPRAGAAVCDTWGRLPLADATVAVLVNVFAPRNGPEFRRVLRPDGALLVVTPTAEHLVELVDRLGLLRVDPAKDARVADSLTRHFEPAGQSTHRHRLQLTRKEVLTLVGMGPSAWHTDPARLTARVAALSEPVTVTAAVRLARYRPI	144.41	gnl|BL_ORD_ID|137|hsp_num:0	158			723	786	tylosin; mycinamicin
BGC0000940.1|Desferrioxamine_5 # 4450 # 5004 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000940.1|Desferrioxamine_5 	4450	5004	+	Loose	275	51.2174	AAC(6')-IIb	27.22	3002595	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGCCGCTTGAGCACCACCACCCCCGTCGGGGCACTGACCCTGCGCCCCGTCGACCCGCTGACGGACGCCGTACTGCTGCACGGCTGGCTCACCCACCCCAAGTCCGCGTTCTGGATGATGCAGGACGCCCGGCTGGTGGACGTCGAGCGGGCCTACATGGAGCTGGCCGCCGACGAGCACCAGCAGGCCCACCTCGGCCTGCACGACGGGGTCCCGGCCTTCCTGACGGAGCGCTACGACCCCGCCCACCGCGAACTGGTCGGGCTGTACGAGCCCGAGCCGGGCGACGTCGGCATGCACTTCCTGGTCGCGCCCACCGACCGGCCCGTGCACGGCTTCACCCGCGCCGTGATCACCACCGTGATGACGGAGCTGTTCGCCGACCCGGCGACCCGGCGGGTCGTCGTCGAACCGGACGTCACCAACACCGCCGTGCACGCCCTGAACGCAGCCGTCGGATTCGTGCCCGAGCGCGAGATCCAGAAGCCGGAGAAGAAGGCCTTGCTGAGCTTCTGCACCCGCGAGCAGTTCGCGAAGGCGGTGTCCGCATGA	MSRLSTTTPVGALTLRPVDPLTDAVLLHGWLTHPKSAFWMMQDARLVDVERAYMELAADEHQQAHLGLHDGVPAFLTERYDPAHRELVGLYEPEPGDVGMHFLVAPTDRPVHGFTRAVITTVMTELFADPATRRVVVEPDVTNTAVHALNAAVGFVPEREIQKPEKKALLSFCTREQFAKAVSA	MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYIGLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA	102.22	gnl|BL_ORD_ID|121|hsp_num:0	140			9	510	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000940.1|Desferrioxamine_6 # 5001 # 6788 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.702	BGC0000940.1|Desferrioxamine_6 	5001	6788	+	Loose	750	26.5646	tet(53)	42.42	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCCTCGCCGACGCCGTCGCCCACCTGACCCCCGAACGCTGGGAGGAGGCCAACCGCCTCCTGGTCCGCAAGGCGCTGGCCGAGTTCACCCACGAGCGGCTGCTGACCCCCGAGCGGGAGCCGGACGACGGGGGCGGGCAGACGTACGTCGTCCGCAGCGACGACGGCCAGACCGCGTACCGCTTCACCGCCACCGTCCGCGCCCTGGACCACTGGCAGGTGGACGCCGCCTCCGTCACCCGCCACCGCGACGGCGCGGAACTCCCGCTCGCCGCGCTGGACTTCTTCATCGAGCTGAAGCAGACCCTGGGCCTGAGCGACGAGATCCTCCCGGTCTACCTGGAGGAGATCTCCTCCACCCTCTCCGGCACCTGCTACAAACTGACCAAGCCGCAGCTCAGCTCCGCCGAGCTGGCCCGGAGCGGAGACTTCCAGGCCGTCGAGACGGGCATGACCGAGGGCCACCCGTGCTTCGTCGCCAACAACGGGCGCCTCGGCTTCGGCATCCACGAGTACCTGTCGTACGCCCCCGAGACCGCGAGCCCGGTCCGGCTGGTGTGGCTGGCCGCGCACCGCTCGCGGGCGGCGTTCACGGCGGGCGTGGGCATCGAGTACGAGTCCTTCGTCCGGGACGAGCTGGGCGCGGCCACCGTCGACCGCTTCCACGGCGTGCTGCGCGGGCGCGGCCTGGACCCGGCCGACTACCTGCTCATCCCGGTCCACCCCTGGCAGTGGTGGAACAAGCTCACCGTCACCTTCGCCGCCGAGGTCGCCCGCGGGCACCTGGTGTGCCTGGGCGAGGGCGACGACGAGTACCTGGCCCAGCAGTCCATCCGCACCTTCTTCAACGCCTCGCACCCCGGGAAGCACTACGTGAAGACTGCCCTGTCCGTCCTCAACATGGGCTTCATGCGCGGTCTGTCGGCGGCGTACATGGAGGCCACTCCGGCCATCAACGACTGGCTCGCCCGGCTGATCGAGGGCGACCCGGTGCTGAAGGAGACGGGGCTGAGCATCATCCGGGAGCGGGCGGCCGTCGGCTACCGGCACCTGGAGTACGAGCAGGCCACCGACCGCTACTCGCCCTACCGCAAGATGCTGGCGGCGCTGTGGCGGGAGAGCCCGGTGCCGTCCATCCGGGAGGGCGAGACGCTCGCCACCATGGCCTCCCTGGTCCACCAGGACCACGAGGGCGCCTCCTTCGCGGGCGCGCTGATCGAGCGGTCCGGACTCACGCCCACCGAGTGGCTGCGGCACTACCTGCGGGCCTACTACGTCCCGCTGCTGCACAGCTTCTACGCCTACGACCTGGTGTACATGCCGCACGGCGAGAACGTGATCCTGGTGCTGGCGGACGGGGTGGTGCGGCGGGCGGTCTACAAGGACATCGCCGAGGAGATCGCGGTGATGGACCCGGACGCGGTGCTGCCGCCGGAGGTCTCCCGCATCGCGGTGGACGTGCCGGACGACAAGAAGCTCCTGTCGATCTTCACGGACGTCTTCGACTGCTTCTTCCGCTTCCTGGCCGCGAACCTGGCGGAGGAGGGGATCGTCACGGAGGACGCCTTCTGGCGGACGGTCGCGGAGGTCACCCGGGAGTACCAGGAGTCGGTGCCGGAGCTGGCCGACAAGTTCGAGCGGTACGACATGTTCGCGCCCGAGTTCGCCCTGTCCTGCCTCAACCGGCTCCAGCTGCGCGACAACCGGCAGATGGTGGACCTGGCCGACCCGTCCGGCGCGCTCCAGCTCGTCGGCACCCTGAAGAACCCCCTGGCAGGCCGGTAG	MSLADAVAHLTPERWEEANRLLVRKALAEFTHERLLTPEREPDDGGGQTYVVRSDDGQTAYRFTATVRALDHWQVDAASVTRHRDGAELPLAALDFFIELKQTLGLSDEILPVYLEEISSTLSGTCYKLTKPQLSSAELARSGDFQAVETGMTEGHPCFVANNGRLGFGIHEYLSYAPETASPVRLVWLAAHRSRAAFTAGVGIEYESFVRDELGAATVDRFHGVLRGRGLDPADYLLIPVHPWQWWNKLTVTFAAEVARGHLVCLGEGDDEYLAQQSIRTFFNASHPGKHYVKTALSVLNMGFMRGLSAAYMEATPAINDWLARLIEGDPVLKETGLSIIRERAAVGYRHLEYEQATDRYSPYRKMLAALWRESPVPSIREGETLATMASLVHQDHEGASFAGALIERSGLTPTEWLRHYLRAYYVPLLHSFYAYDLVYMPHGENVILVLADGVVRRAVYKDIAEEIAVMDPDAVLPPEVSRIAVDVPDDKKLLSIFTDVFDCFFRFLAANLAEEGIVTEDAFWRTVAEVTREYQESVPELADKFERYDMFAPEFALSCLNRLQLRDNRQMVDLADPSGALQLVGTLKNPLAGR	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	153.75	gnl|BL_ORD_ID|2724|hsp_num:0	3290			279	363	tetracycline; minocycline; oxytetracycline
